Gases and Volatile Poisons: CO, Cyanide, Methanol, Ethanol

Carbon monoxide forms carboxyhaemoglobin (COHb), reducing available oxygen-carrying capacity and impairing release of oxygen from remaining haemoglobin sites. Effects on other haem proteins and cellular processes also contribute. It is not simply a gas that lowers the oxygen partial pressure measured in plasma.

A normal conventional pulse-oximeter reading or arterial oxygen partial pressure does not reliably exclude poisoning. Suitable blood co-oximetry distinguishes relevant haemoglobin forms within its analytical capability. Symptoms and exposure history remain essential, particularly if oxygen was administered before collection.

Combustion sources include malfunctioning fuel-burning appliances, generators, fires, engines and charcoal used in enclosed spaces. Source patterns depend on the setting and season; they should not be reduced to an unsupported list of national laboratory case volumes.

COHb can fall after exposure stops, especially during oxygen treatment. A low later result does not reconstruct the peak burden. Conversely, an elevated COHb result supports exposure but does not establish one universal fatal threshold or determine the contribution of every other fire hazard.

Pink or cherry-red lividity is variable and non-specific. Cold exposure, storage and other circumstances can produce similar appearances. Never use colour as a substitute for appropriate analysis or assume that a particular COHb percentage alone distinguishes thermal death from smoke toxicity.

Validated laboratory approaches can include optical or gas-based measurements with appropriate preparation and calibration. Haemolysis, decomposition, interfering pigments and treatment can complicate particular methods. Collection container, sealing, storage and acceptable holding conditions should follow the laboratory's supported procedure.

Cyanide can inhibit mitochondrial cytochrome c oxidase and disrupt oxidative metabolism. Severe exposure can progress rapidly, but onset and outcome depend on route, formulation, amount, treatment and individual factors. Fixed lethal doses and guaranteed collapse times should not be taught as predictive rules.

Potential sources include industrial materials, combustion smoke and some cyanogenic plants or products. A suspected source helps select testing but does not prove exposure. CO and cyanide can coexist in fire victims, alongside thermal injury and other inhalation hazards.

The presence or absence of a bitter-almond description is unreliable. People differ in odour perception and exposure circumstances, and deliberately smelling a specimen creates a hazard. Do not use a claimed percentage of genetically unable observers as a substitute for a safe analytical procedure.

Cyanide assays differ in whether they measure a particular available fraction, total content after a specified preparation, or a derivative. Chemical conditions can affect liberation and recovery. State the operational measurand and validate the method for the specimen.

Microdiffusion can separate liberated HCN into a trap before detection in an appropriate controlled method. Chromatographic or other selective measurements are also used. A colour response is not automatically unique identity, and one microdiffusion recipe is not the mandatory international workflow.

Clinical antidotal approaches include direct binding by hydroxocobalamin and other authorised treatments with different mechanisms. Nitrite-based treatment can worsen oxygen-carrying capacity through methaemoglobin formation, which matters in smoke exposure. Drug choice and administration require current clinical protocols and expert assessment, including co-exposure and oxygen-delivery concerns.

Methanol is converted through formaldehyde to formate. Accumulation of toxic metabolites contributes to metabolic acidosis and visual and neurological injury. The parent compound can also produce early effects, so describing it as harmless until metabolism is incorrect.

Symptoms may be delayed, but there is no fixed safe symptom-free interval. Concurrent ethanol can alter metabolism and the time course. A person with a relevant suspected exposure needs prompt clinical assessment even when initial symptoms or routine chemistry appear mild.

Appropriate chromatography can measure methanol and other selected alcohols in a validated panel. A method must demonstrate separation from relevant volatiles and matrix components, calibration, quality controls and reporting capability. A generic headspace peak does not uniquely identify methanol.

Interpret measured methanol with collection timing, treatment, ethanol, acid–base findings and, where available and appropriate, formate. A late concentration can differ substantially from the earlier burden. Neither a normal anion gap early in exposure nor one later parent concentration completely answers the toxicity question.

Treatment principles include inhibiting further toxic metabolism and managing severe metabolic effects. Fomepizole and clinically supervised ethanol are different ways to inhibit alcohol-dehydrogenase-mediated metabolism. They require proper protocols, monitoring and consideration of the patient's circumstances.

Extracorporeal-treatment recommendations consider clinical severity and laboratory findings, and can use different concentration criteria depending on antidotal treatment. A universal “dialyse above 50 mg/dL” rule omits important conditions. Forensic teaching should explain the rationale without supplying an incomplete bedside dosing protocol.

Ethanol affects the central nervous system through several mechanisms. Concentration, rate of change, tolerance, co-exposures and vulnerability influence effects. No one blood concentration is invariably fatal or proves the same degree of impairment in every person.

Validated headspace GC methods commonly measure ethanol in blood and other suitable matrices. Internal standards, calibration, chromatographic separation and quality controls support the result. Dual-column or other identification approaches must be evaluated as part of the actual method, not treated as an instrument-name guarantee.

Post-mortem microorganisms can produce ethanol. The amount depends on specimen condition, substrates, organisms, temperature and time. A fixed claim that every unpreserved sample develops 30–50 mg/dL after 48 hours is unsupported and should not guide case conclusions.

Suitable preservatives, containers and controlled storage reduce some risks but do not reverse ethanol production that occurred before collection. Document the anatomical source and state of each specimen. Peripheral blood, urine and vitreous can provide complementary evidence when available and suitable.

Vitreous is relatively protected, but not immune to contamination or post-mortem change. Agreement across matrices can support an interpretation; disagreement has several possible explanations. A near-zero vitreous result is not automatic proof that all blood ethanol arose after death.

Urine–blood relationships vary with absorption, distribution, renal accumulation and timing. A fixed ratio cannot timestamp drinking or prove a particular phase in every case. Back-calculation to an earlier event requires explicit assumptions and an appropriate range, and may be unjustified when absorption or timing is uncertain.

In the United States, driving rules vary by state and driver category. The UK includes differing national limits; India, Canada and Australia have their own frameworks. Breath and blood limits and evidential procedures must be checked for the relevant jurisdiction rather than converted through one universal physiological ratio.

COHb measurement addresses CO binding in blood; cyanide testing addresses a different target and analytical challenge. Methanol and ethanol can be included in some shared chromatographic panels, but their mechanisms and interpretation differ. A result for one does not stand in for the others.

Fire deaths can involve combined exposures and injury. Evaluate scene findings, survival interval, treatment, airway and pathological findings together with toxicology. A high COHb burden need not mean that cyanide or thermal injury had no role.

For suspected contaminated alcohol, analyse biological specimens and the recovered liquid as separate exhibits with appropriate methods. Finding the same alcohols supports an association, but their common presence does not uniquely identify one bottle as the source.

Concentration comparisons across blood, vitreous and a product require correct units and matrix interpretation. Product percentage, blood mg/dL and gas concentration in air are different quantities. An analytical association alone cannot determine intent, administration route or legal responsibility.

Prioritise emergency care and responder safety. Collect suitable specimens as promptly as practical under the applicable procedure, documenting exposure and treatment times. A delayed forensic request should not erase the information that oxygen, an antidote or dialysis preceded collection.

Discuss suspected targets with the laboratory before choosing containers and storage where feasible. Fill and seal requirements differ across specimen types and methods. Avoid repeated opening or unnecessary transfers that can lose volatile material or introduce contamination.

Keep biological specimens separate from source liquids and scene exhibits. Record identifiers, condition, preservatives and custody transfers. Environmental air measurement, a product assay and a biological result require methods suited to their respective matrices.

The report should state which compounds or fractions were tested, the analytical result and relevant limitations. A negative routine alcohol screen cannot exclude CO, cyanide or every solvent. Further testing may be needed when the suspected target lies outside the panel.

A suspected cluster requires coordinated clinical, public-health and analytical work. Establish specimen priorities, clear identifiers and communication about the suspected shared source. Record the criteria used to define the cluster rather than assuming every illness after an event has the same cause.

Rapid testing capacity should retain controls and data review. A large workload does not justify reporting an unresolved peak as a confirmed poison. Separate preliminary communications from final findings and document any revised interpretation.

Surge planning includes confirmed referral contacts, available analytical capacity, specimen transport and agreed routes for preliminary results. Services should check these arrangements before an incident and review them as staffing, equipment and clinical needs change.

A causal conclusion draws on the combined evidence. Toxicology can demonstrate and quantify selected substances, while clinical, pathological and scene findings address their contribution to injury or death. The strongest report makes clear which conclusions are measured and which are interpretive.

Related reading: Post-Mortem Examination and Viscera Collection in Poisoning.

Related reading: Distillation, Microdiffusion and Dialysis Techniques.

Related reading: Signs, Symptoms and Antidotes of Common Poisons.